Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Spectrum Analysis × Gastrointestinal × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Gastrointestinal 1

Conditions

Barrett Esophagus 1 Adenocarcinoma Of Esophagus 1

Interventions

Oxaliplatin 649 Fluorouracil 548 Capecitabine 469 Gemcitabine 405 Leucovorin 396 Irinotecan 378 Bevacizumab 363 Cisplatin 279 Radiotherapy 242 Cetuximab 208 Paclitaxel 151 pembrolizumab 146 S 1 (combination) 145 Docetaxel 136 Drug Therapy 120 Nivolumab 116 apatinib 110 tislelizumab 108 sintilimab 107 130-nm albumin-bound paclitaxel 101 durvalumab 100 Folfox protocol 97 Surgical Procedures, Operative 91 Albumin-Bound Paclitaxel 91 Panitumumab 89 lenvatinib 88 camrelizumab 88 Sorafenib 88 regorafenib 81 Radiation 78

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05745857 2023-02-27

SLURP

University Medical Center Groningen

Phase 2 Unknown

Gastrointestinal

Adenocarcinoma Of Esophagus, Barrett Esophagus

Data powered by HemOnc (CC BY 4.0) Colophon ⚡